McKesson Co. (NYSE:MCK) EVP Thomas L. Rodgers sold 198 shares of McKesson stock in a transaction dated Tuesday, June 8th. The shares were sold at an average price of $192.85, for a total value of $38,184.30. Following the completion of the sale, the executive vice president now directly owns 1,161 shares in the company, valued at approximately $223,898.85. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
Thomas L. Rodgers also recently made the following trade(s):
- On Tuesday, June 1st, Thomas L. Rodgers sold 145 shares of McKesson stock. The shares were sold at an average price of $189.56, for a total value of $27,486.20.
McKesson stock opened at $195.51 on Friday. McKesson Co. has a 52 week low of $139.76 and a 52 week high of $204.66. The company has a debt-to-equity ratio of 82.70, a current ratio of 1.03 and a quick ratio of 0.59. The company has a market capitalization of $30.93 billion, a PE ratio of -6.83, a P/E/G ratio of 1.47 and a beta of 0.88. The stock’s 50-day simple moving average is $193.79.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 1st. Stockholders of record on Tuesday, June 1st will be issued a dividend of $0.42 per share. This represents a $1.68 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date is Monday, May 31st. McKesson’s dividend payout ratio is presently 9.76%.
Several large investors have recently modified their holdings of the company. KB Financial Partners LLC bought a new stake in shares of McKesson during the first quarter worth approximately $38,000. Rehmann Capital Advisory Group boosted its holdings in shares of McKesson by 4.7% during the first quarter. Rehmann Capital Advisory Group now owns 7,383 shares of the company’s stock worth $1,440,000 after acquiring an additional 329 shares during the period. Schroder Investment Management Group boosted its holdings in shares of McKesson by 0.6% during the first quarter. Schroder Investment Management Group now owns 121,351 shares of the company’s stock worth $23,668,000 after acquiring an additional 744 shares during the period. Kingsview Wealth Management LLC boosted its holdings in shares of McKesson by 12.2% during the first quarter. Kingsview Wealth Management LLC now owns 2,425 shares of the company’s stock worth $469,000 after acquiring an additional 263 shares during the period. Finally, Pendal Group Limited boosted its holdings in shares of McKesson by 6.3% during the first quarter. Pendal Group Limited now owns 29,933 shares of the company’s stock worth $5,838,000 after acquiring an additional 1,766 shares during the period. Institutional investors own 85.34% of the company’s stock.
Several equities analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft raised their price objective on McKesson from $231.00 to $237.00 and gave the company a “buy” rating in a report on Friday, May 7th. Mizuho raised their price objective on McKesson from $190.00 to $205.00 and gave the company a “neutral” rating in a report on Wednesday, May 12th. Argus upgraded McKesson from a “hold” rating to a “buy” rating and set a $230.00 price objective for the company in a report on Tuesday, March 30th. Cowen raised their price objective on McKesson from $210.00 to $224.00 and gave the company an “outperform” rating in a report on Tuesday, March 2nd. Finally, Credit Suisse Group raised their price objective on McKesson from $192.00 to $222.00 and gave the company a “neutral” rating in a report on Monday, May 10th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $209.18.
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).
Further Reading: What is a Roth IRA?
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.